Balashov K E, Khoury S J, Hafler D A, Weiner H L
Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
J Clin Invest. 1995 Jun;95(6):2711-9. doi: 10.1172/JCI117973.
The autologous mixed lymphocyte reaction (AMLR) involves the activation of T cells by autologous antigen presenting cells. Cells are generated during the course of the AMLR that have suppressive properties in vitro. In the present study we investigated the induction of CD8+ T cells in the AMLR with suppressive properties and the mechanism by which these cells downregulate in vitro proliferative responses. Purified CD8+ but not CD4+ T cells activated in the AMLR in conditioned medium inhibited proliferation of autologous T cells by anti-CD3 or PPD. Nonactivated CD8+ T cells did not suppress. The CD8+ T cells activated in the AMLR in the presence of conditioned medium (CD8+ Tact) were CD11b negative and were noncytotoxic. The inhibitory effect of CD8+ Tact cells was completely abrogated by anti-IFN-gamma antibody, but not by anti-IL-4, anti-IL-10, or anti-TGF-beta antibody. The induction of CD8+ Tact cells in the AMLR was blocked by anti-IL-2 or by anti-GM-CSF antibody and the combination of these two recombinant cytokines could support the induction of suppressive CD8+ Tact cells. CD8+ Tact cells were defective in patients with chronic progressive multiple sclerosis (MS) as compared to patients with relapsing-remitting MS or normal controls. Our studies provide a basis for understanding the mechanism of suppression by human CD8+ T cells in terms of specific cytokines, and demonstrate the potential importance of these cells in a human autoimmune disease as their function is defective in patients with progressive MS.
自体混合淋巴细胞反应(AMLR)涉及自体抗原呈递细胞对T细胞的激活。在AMLR过程中会产生在体外具有抑制特性的细胞。在本研究中,我们调查了具有抑制特性的AMLR中CD8⁺T细胞的诱导情况以及这些细胞下调体外增殖反应的机制。在条件培养基中于AMLR中激活的纯化CD8⁺而非CD4⁺T细胞,通过抗CD3或PPD抑制自体T细胞的增殖。未激活的CD8⁺T细胞无抑制作用。在条件培养基存在下于AMLR中激活的CD8⁺T细胞(CD8⁺Tact)CD11b阴性且无细胞毒性。CD8⁺Tact细胞的抑制作用被抗IFN-γ抗体完全消除,但抗IL-4、抗IL-10或抗TGF-β抗体则无此作用。AMLR中CD8⁺Tact细胞的诱导被抗IL-2或抗GM-CSF抗体阻断,这两种重组细胞因子的组合可支持抑制性CD8⁺Tact细胞的诱导。与复发缓解型多发性硬化症(MS)患者或正常对照相比,慢性进行性MS患者的CD8⁺Tact细胞存在缺陷。我们的研究为从特定细胞因子角度理解人类CD8⁺T细胞的抑制机制提供了基础,并证明了这些细胞在人类自身免疫性疾病中的潜在重要性,因为其功能在进行性MS患者中存在缺陷。